This analysis is limited by the lack of direct access to the referenced Saudi Arabian systematic review on genetic and environmental risk factors for autism spectrum disorder (ASD). Since the original article’s full text could not be reviewed, this article will instead provide an evidence-based synthesis of current knowledge on ASD risk factors worldwide—emphasizing genetics, environment, and population-level effects—with relevance to Saudi Arabia and the broader Middle East. While awaiting a direct review of the study, what follows is a medically accurate, globally relevant perspective on ASD risk science, public health, and what clinicians and families need to know.
Understanding Autism Spectrum Disorder
Autism spectrum disorder is a complex neurodevelopmental condition with lifelong impacts on communication, behavior, and social interaction. The prevalence of ASD has steadily risen in recent decades, driven by greater awareness, broader diagnostic criteria, and likely, environmental and lifestyle changes. Globally, about 1 in 100 children are now diagnosed with ASD, according to the World Health Organization, though estimates vary by region and surveillance system.
Genetic and Environmental Risk Factors
The causes of ASD remain incompletely understood, but research consistently supports a multifactorial etiology—genes and environment interact in ways that are not yet fully mapped.
Genetic influences: Large-scale genomic studies confirm that hundreds of genes contribute to ASD risk, many involved in brain development, synaptic function, and neuron communication. These genetic risks can be inherited or arise spontaneously as new mutations. Twin studies—the gold standard for disentangling nature from nurture—show higher concordance rates for ASD in identical compared to fraternal twins, underscoring the strong genetic component.
Environmental factors: A range of potential environmental influences have been investigated, though concrete causal links remain uncertain and often population-specific. Factors that may increase risk—especially when combined with genetic vulnerability—include advanced parental age, maternal illness or infections during pregnancy, birth complications, very preterm birth, and exposure to certain medications or environmental chemicals. However, no single environmental factor has been shown to cause ASD, and the evidence overall is more suggestive than definitive.
Gene-environment interactions: Research increasingly points to interplay between genes and environment. For example, genetic susceptibility may make some individuals more vulnerable to environmental triggers, but robust, replicated gene-environment interaction studies in ASD are still rare, especially in non-European populations.
Middle East and Saudi Arabia: Context and Gaps
In Saudi Arabia and neighboring countries, ASD research is growing but still lags behind North America, Europe, and parts of Asia in scale and reporting transparency. Cultural awareness of ASD has increased, yet diagnostic delays and unequal access to early intervention are still challenges in some communities. While the referenced systematic review may shed new light on risk factors in the Saudi population, the core science remains consistent with global patterns: heritability is strong, environmental factors are likely modifiers, and both need ongoing study in diverse populations.
Among challenges specific to the Middle East are higher rates of consanguinity in some communities, which can increase the likelihood of rare genetic conditions associated with ASD. There is also emerging interest in local environmental exposures—such as air quality, nutritional factors, and maternal health disparities—but these require careful, population-specific research.
Public Health Implications
Understanding ASD risk factors is not just academic. Early identification of ASD leads to earlier intervention, which can improve long-term outcomes for children and families. Genetic counseling, for those at higher familial risk, may help families make informed reproductive choices. And while the science of prevention is still evolving, public health efforts to promote healthy pregnancies, reduce harmful environmental exposures, and improve access to perinatal care are supported by broad consensus.
Globally, the burden of neurodevelopmental disorders like ASD falls disproportionately on low- and middle-income countries, where services are often scarce and stigma remains high. In Saudi Arabia, recent public health campaigns have sought to improve early screening, reduce stigma, and expand support services—efforts that must continue and be rigorously evaluated.
Expert Commentary and Caution
Experts warn against overstating the role of any single risk factor, genetic or environmental. “The biology is complex, and risks are additive, interactive, and sometimes population-specific,” explains a leading pediatric neurologist at a major academic medical center. “What we know for sure is that early diagnosis and access to evidence-based therapies offer the best chance for better outcomes—regardless of the cause.”
Some commercial entities promote unproven “detox” or “cure” products targeting environmental risks—these lack scientific support and sometimes delay families from pursuing evidence-based care. Clinics and governments in the region must remain vigilant against misinformation and predatory marketing.
Why This Matters
This field matters because every child with ASD—and every family—deserves science-based care, not rumor or pseudoscience. The more we understand about risk factors, the better we can target prevention, early detection, and intervention—helping to build healthier futures for vulnerable children in Saudi Arabia and worldwide. The findings of local systematic reviews, when available, should inform culturally tailored public health strategies and help close regional gaps in ASD science.
For ongoing coverage of developmental health and access to expert panels, follow Globally Pulse Health.
